These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1035 related items for PubMed ID: 31406106

  • 41. Methylation-regulated tumor suppressor gene PDE7B promotes HCC invasion and metastasis through the PI3K/AKT signaling pathway.
    Du Y, Xu Y, Guo X, Tan C, Zhu X, Liu G, Lyu X, Bei C.
    BMC Cancer; 2024 May 22; 24(1):624. PubMed ID: 38778317
    [Abstract] [Full Text] [Related]

  • 42.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 43. Transcription factor 7 like 2 promotes metastasis in hepatocellular carcinoma via NEDD9-mediated activation of AKT/mTOR signaling pathway.
    Tang L, Xu S, Wei R, Fan G, Zhou J, Wei X, Xu X.
    Mol Med; 2024 Jul 25; 30(1):108. PubMed ID: 39060928
    [Abstract] [Full Text] [Related]

  • 44. SRPX2, an independent prognostic marker, promotes cell migration and invasion in hepatocellular carcinoma.
    Lin X, Chang W, Wang Y, Tian M, Yu Z.
    Biomed Pharmacother; 2017 Sep 25; 93():398-405. PubMed ID: 28654796
    [Abstract] [Full Text] [Related]

  • 45. TRAF4 Regulates Migration, Invasion, and Epithelial-Mesenchymal Transition via PI3K/AKT Signaling in Hepatocellular Carcinoma.
    Liu K, Wu X, Zang X, Huang Z, Lin Z, Tan W, Wu X, Hu W, Li B, Zhang L.
    Oncol Res; 2017 Sep 21; 25(8):1329-1340. PubMed ID: 28256185
    [Abstract] [Full Text] [Related]

  • 46. Role of IQGAP3 in metastasis and epithelial-mesenchymal transition in human hepatocellular carcinoma.
    Shi Y, Qin N, Zhou Q, Chen Y, Huang S, Chen B, Shen G, Jia H.
    J Transl Med; 2017 Aug 15; 15(1):176. PubMed ID: 28810875
    [Abstract] [Full Text] [Related]

  • 47. Knocking down FAM83B inhibits endometrial cancer cell proliferation and metastasis by silencing the PI3K/AKT/mTOR pathway.
    Lin Q, Chen H, Zhang M, Xiong H, Jiang Q.
    Biomed Pharmacother; 2019 Jul 15; 115():108939. PubMed ID: 31079003
    [Abstract] [Full Text] [Related]

  • 48. BEZ235 Increases the Sensitivity of Hepatocellular Carcinoma to Sorafenib by Inhibiting PI3K/AKT/mTOR and Inducing Autophagy.
    Cao W, Liu X, Zhang Y, Li A, Xie Y, Zhou S, Song L, Xu R, Ma Y, Cai S, Tang X.
    Biomed Res Int; 2021 Jul 15; 2021():5556306. PubMed ID: 33987439
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. miR-210 promotes hepatocellular carcinoma progression by modulating macrophage autophagy through PI3K/AKT/mTOR signaling.
    Bi S, Zhang Y, Zhou J, Yao Y, Wang J, Fang M, Li B, Wu C, Ren C.
    Biochem Biophys Res Commun; 2023 Jun 25; 662():47-57. PubMed ID: 37099810
    [Abstract] [Full Text] [Related]

  • 51. microRNA-1914, which is regulated by lncRNA DUXAP10, inhibits cell proliferation by targeting the GPR39-mediated PI3K/AKT/mTOR pathway in HCC.
    Sun L, Wang L, Chen T, Yao B, Wang Y, Li Q, Yang W, Liu Z.
    J Cell Mol Med; 2019 Dec 25; 23(12):8292-8304. PubMed ID: 31576658
    [Abstract] [Full Text] [Related]

  • 52. Interleukin-8 promotes integrin β3 upregulation and cell invasion through PI3K/Akt pathway in hepatocellular carcinoma.
    Sun F, Wang J, Sun Q, Li F, Gao H, Xu L, Zhang J, Sun X, Tian Y, Zhao Q, Shen H, Zhang K, Liu J.
    J Exp Clin Cancer Res; 2019 Nov 04; 38(1):449. PubMed ID: 31684995
    [Abstract] [Full Text] [Related]

  • 53. E2F1 mediated DDX11 transcriptional activation promotes hepatocellular carcinoma progression through PI3K/AKT/mTOR pathway.
    Yu Y, Zhao D, Li K, Cai Y, Xu P, Li R, Li J, Chen X, Chen P, Cui G.
    Cell Death Dis; 2020 Apr 24; 11(4):273. PubMed ID: 32332880
    [Abstract] [Full Text] [Related]

  • 54. Curzerene suppresses hepatocellular carcinoma progression through the PI3K/AKT/MTOR pathway.
    Luo Y, Wang Z, Jiang J, Wu S, Zhai Y.
    Rev Invest Clin; 2024 Jul 24; 76(4):173-184. PubMed ID: 39047236
    [Abstract] [Full Text] [Related]

  • 55. Long noncoding RNA PICSAR/miR-588/EIF6 axis regulates tumorigenesis of hepatocellular carcinoma by activating PI3K/AKT/mTOR signaling pathway.
    Liu Z, Mo H, Sun L, Wang L, Chen T, Yao B, Liu R, Niu Y, Tu K, Xu Q, Yang N.
    Cancer Sci; 2020 Nov 24; 111(11):4118-4128. PubMed ID: 32860321
    [Abstract] [Full Text] [Related]

  • 56. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH, Niu H, Li Z, Huo RT, Wang JM, Liu J.
    Cancer Biomark; 2018 Nov 24; 23(1):33-43. PubMed ID: 29991125
    [Abstract] [Full Text] [Related]

  • 57. [P4HA2 promotes occurrence and progression of liver cancer by regulating the PI3K/Akt/mTOR signaling pathway].
    Shang L, Jiang W, Zhang J, Wu W.
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 May 20; 42(5):665-672. PubMed ID: 35673909
    [Abstract] [Full Text] [Related]

  • 58. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL, Wang WY, Yao WQ, Li GD.
    Int J Mol Med; 2015 Dec 20; 36(6):1713-9. PubMed ID: 26499886
    [Abstract] [Full Text] [Related]

  • 59. FDX1 downregulation activates mitophagy and the PI3K/AKT signaling pathway to promote hepatocellular carcinoma progression by inducing ROS production.
    Sun B, Ding P, Song Y, Zhou J, Chen X, Peng C, Liu S.
    Redox Biol; 2024 Sep 20; 75():103302. PubMed ID: 39128228
    [Abstract] [Full Text] [Related]

  • 60. Overexpression of CXCL5 mediates neutrophil infiltration and indicates poor prognosis for hepatocellular carcinoma.
    Zhou SL, Dai Z, Zhou ZJ, Wang XY, Yang GH, Wang Z, Huang XW, Fan J, Zhou J.
    Hepatology; 2012 Dec 20; 56(6):2242-54. PubMed ID: 22711685
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 52.